Advanced glycation end products contribute to amyloidosis in Alzheimer disease

Proceedings of the National Academy of Sciences of the United States of America

Volumn 91, Issue 11, 1994, Pages 4766-4770

  Vitek, Michael P ^a   Bhattacharya, Keshab ^a   Glendening, J Michael ^a   Stopa, Edward ^b   Vlassara, Helen ^a   Bucala, Richard ^a   Manogue, Kirk ^a   Cerami, Anthony ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

amyloid peptide; aggregation; nucleation dependent kinetics; seed structure and function

Indexed keywords

AMINOGUANIDINE; AMYLOID BETA PROTEIN; GLUCOSE; MONOMER; THIOFLAVINE;

ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; GLYCATION; HUMAN; HUMAN TISSUE; KINETICS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN CROSS LINKING; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLUCOSE; GLYCOSYLATION; HUMAN; KINETICS; SUPPORT, NON-U.S. GOV'T;

EID: 0028363366     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.91.11.4766     Document Type: Article

References (26)